NCT03183674

Oxytocin in Spectrum Autism Disorders

Oxytocin in Individuals With Spectrum Autism Disorders

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: University of Sao Paulo General Hospital · Academic / Other
• Sex: All
• Age: 3 Years – 16 Years
• Healthy volunteers: Accepted

Summary

Observe effects of oxytocin on individuals with autism spectrum disorder

Detailed description

To observe the effects of oxytocin on individuals with autism spectrum disorder according to gender, in facial recognition and eye tracking tests. The investigators will apply the nepsy and eye tracking tests before and 45 minutes after the puff with oxytocin or placebo at the dose of 0.4 IU / kg / dose maximum of 24 IU. The next week the volunteer will return and will do the same procedure because whoever took the placebo would take oxytocin and vice versa. Is a randomized, double-blind, placebo-controlled clinical trial.

Conditions

• Autistic Disorder

Interventions

Type	Name	Description
DRUG	Oxytocin	Single dose oxytocin 45 minutes before the test
OTHER	placebo	saline solution 0,9% spray nasal

Timeline

• Start date: 2016-07-15
• Primary completion: 2017-07-20
• Completion: 2018-05-15
• First posted: 2017-06-12
• Last updated: 2019-10-28

Locations

1 site across 1 country: Brazil